Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $8.97M in the quarter ending June 30, 2026, a decrease of -61.33%. This brings the company's revenue in the last twelve months to $28.73M, down -83.86% year-over-year. In the year 2025, Monte Rosa Therapeutics had annual revenue of $123.67M with 63.54% growth.

• Revenue (ttm): $28.73M
• Revenue Growth: -83.86%
• P/S Ratio: 41.79
• Revenue / Employee: $166,052
• Employees: 173
• Market Cap: 1.20B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	123.67M	48.05M	63.54%
Dec 31, 2024	75.62M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error